LabCorp Clinical Trials
Pharmaceutical Manufacturing201-500 Employees
LabCorp Clinical Trials operates in the pharmaceutical manufacturing industry and employs between 201 and 500 people; its website is labcorp.com. It forms part of Labcorp and Covance, providing end-to-end drug development support through Covance Drug Development and clinical laboratory services through LabCorp Diagnostics, with plans to operate together under the Covance brand. The company serves a range of healthcare stakeholders, including physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs. Recent activities include the June 2026 launch of ColoSense, an FDA-approved RNA-based at-home colorectal cancer screening test, and the May 2026 introduction of MyLabcorp, an AI-powered mobile app to help consumers understand lab results and track health trends. In 2019 LabCorp disclosed a cybersecurity incident involving unauthorized access to protected health information, and in June 2026 it agreed to pay $35 million to settle an AMCA data breach.